Company intelligence / Profile preview
Arcutis Biotherapeutics
Westlake Village, California, United States
- Ownership
- Public · ARQT
- Employees
- ~326
- Development stage
- Other
01
Overview
Arcutis Biotherapeutics is a clinical-stage biotech specializing in medical dermatology, with a focus on innovative, nonsteroidal, topical treatments for immune-mediated skin diseases. The company has a commercial-stage PDE4 inhibitor, roflumilast, approved for seborrheic dermatitis, and is advancing late-stage programs for psoriasis, atopic dermatitis, and alopecia areata. Its development platform leverages proprietary topical formulations to optimize drug delivery and tolerability. Arcutis emphasizes unmet needs in chronic inflammatory skin conditions and collaborates closely with dermatology clinicians.
- Therapeutic areas
- Dermatology
- Modalities
- Small moleculeBiologicRecombinant fusion protein
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →03
Partnerships
Odell Beckham Jr. (patient awareness initiative for seborrheic dermatitis)
Beyond the preview
Go deeper on Arcutis Biotherapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Arcutis Biotherapeutics.